{"filing":{"accession_number":"0001935979-26-000060","cik":"0001935979","ticker":"BHVN","company_name":"Biohaven Ltd.","form":"8-K","filing_date":"2026-08-07","report_date":"2026-08-03","primary_document":"bhvn-20260803.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597926000060/bhvn-20260803.htm"},"events":[{"id":26251,"run_id":23843,"accession_number":"0001935979-26-000060","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"The filing discloses the appointment of John Yetimoglu as a director of Biohaven Ltd., effective August 6, 2026, and his appointment to the Nominating and Governance Committee. While the disclosure also includes compensatory details (options with $713,875 grant date fair value and a $57,000 annual retainer), the principal disclosed action is the director appointment itself, making this an exec_appointment event. Director appointments are material to investors as they affect board composition and governance.","company_name":"Biohaven Ltd.","ticker":"BHVN","filing_date":"2026-08-07","form":"8-K","submitted_at":null,"items":[{"id":27295,"accession_number":"0001935979-26-000060","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of John Yetimoglu as a director of Biohaven Ltd., effective August 6, 2026, and his appointment to the Nominating and Governance Committee. While the disclosure also includes compensatory details (options with $713,875 grant date fair value and a $57,000 annual retainer), the principal disclosed action is the director appointment itself, making this an exec_appointment event. Director appointments are material to investors as they affect board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:19:49.695062+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27295,"accession_number":"0001935979-26-000060","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of John Yetimoglu as a director of Biohaven Ltd., effective August 6, 2026, and his appointment to the Nominating and Governance Committee. While the disclosure also includes compensatory details (options with $713,875 grant date fair value and a $57,000 annual retainer), the principal disclosed action is the director appointment itself, making this an exec_appointment event. Director appointments are material to investors as they affect board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:19:49.695062+00:00","company_name":"Biohaven Ltd.","ticker":"BHVN","filing_date":"2026-08-07"}]}